SCMP Financial Facts

Diluted net income (loss) per share: -0.08
Contract and collaboration revenue: 164K
See Full Income Statement

Commitments (Note 7): 0
Accrued expenses: 7.85M
See Full Balance Sheet

Earnings History for Sucampo Pharmaceuticals (SCMP)

  |   Expand Research on SCMP
Next EPS Date 6/7/13 *Est. EPS Growth Rate +433.3% *Last Qtr.
Average EPS % Beat Rate -308.3% Revenue Growth Rate +145.4% *Last Qtr.
Average % Move 1-Wk after EPS +32.1%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
3/13/13 Q412 $0.32$0.12 +$0.20$34.9M$32.21M N/A / N/A N/A +81.8% Details
3/13/12 Q411 $0.06N/A N/A $14.22M$15.9M N/A / N/A N/A +18.9% Details
11/3/11 Q311 -$0.10N/A N/A $14.37M$20.9M N/A / N/A N/A +125% Details
3/3/11 Q410 -$0.15-$0.01 -$0.14$12.4M$15.5M N/A / N/A N/A +110.3% Details
Like SCMP Earnings? Also take a look at ABT, NDAQ, NLNK, SGNT

SCMP Earnings News